Apimeds Pharmaceuticals Us is a pharmaceutical company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker APUS on the NYSEMKT exchange.
Apimeds Pharmaceuticals Us stock last closed at $1.78, up 3.61% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by N/A percentage points. Apimeds Pharmaceuticals Us stock is currently +29.93% from its 52-week low of $1.37, and -55.5% from its 52-week high of $4.00.
At the moment, there are 11.58M shares of APUS outstanding. The market value of APUS is $20.61M. In the last 24 hours, 21,500 APUS shares were traded.
You need an online brokerage account to access the NYSEMKT market and buy APUS stock.
We believe that eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal details so you are able to buy APUS today.
Now that you've created your account on one of the best stock trading apps, you need to deposit funds:
Watch the video below if you need help transferring funds into your investment account.
After you have decided on the best place to buy Apimeds Pharmaceuticals Us stock, it's important to analyze their stock before you buy, so you actually wrap your head around the risk and opportunity.
WallStreetZen was created to help part-time investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on APUS's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge APUS's fair value.
You can do additional valuation analysis on APUS's stock here.
Over the last 12 months, insiders at APUS have bought more shares than they have sold.
Christopher Kim, Chairman and CMO of APUS, was the latest APUS insider to buy. They bought $14,377.80 worth of APUS stock on May 14, 2025.
Get more info about who owns APUS shares here.
No, Apimeds Pharmaceuticals Us doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two primary types of orders:
Hit the Open button and eToro will execute your order.
If you need more info about buying stocks on eToro, watch the how to video below:
Now that you own some APUS stock, you'll want to stay up-to-date on your company.
Put APUS on a watchlist to get notified of important updates regarding your APUS stock.
To reiterate, here are the 6 steps you need to take to buy Apimeds Pharmaceuticals Us stock right now:
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to track your investment in Apimeds Pharmaceuticals Us, hit the button below to create your watchlist.